Literature DB >> 23798910

Reconstructing the Hsp90/Tau Machine.

Umesh K Jinwal1, John Koren, Chad A Dickey.   

Abstract

Imbalanced protein load within cells is a critical aspect for most diseases of aging. In particular, the accumulation of proteins into neurotoxic aggregates is a common thread for a host of neurodegenerative diseases. Recent work demonstrates that age-related changes to the cellular chaperone repertoire contributes to abnormal buildup of the microtubule-associated protein tau that accumulates in a group of diseases termed tauopathies, the most common being Alzheimer's disease (AD). The Hsp90 co-chaperone repertoire has diverse effects on tau stability; some co-chaperones stabilize tau while others facilitate its clearance. We propose that each of these proteins may be novel therapeutic targets. While targeting Hsp90 directly may be deleterious at the organismal level, perhaps targeting individual co-chaperone activities will be more tolerable.

Entities:  

Year:  2013        PMID: 23798910      PMCID: PMC3689215          DOI: 10.2174/1573408011309010006

Source DB:  PubMed          Journal:  Curr Enzym Inhib        ISSN: 1573-4080


  39 in total

Review 1.  Regulatory role of SH3 domain-mediated protein-protein interactions in synaptic vesicle endocytosis.

Authors:  P S McPherson
Journal:  Cell Signal       Date:  1999-04       Impact factor: 4.315

Review 2.  The proteasome.

Authors:  William S Dalton
Journal:  Semin Oncol       Date:  2004-12       Impact factor: 4.929

3.  FKBP51, a novel T-cell-specific immunophilin capable of calcineurin inhibition.

Authors:  G Baughman; G J Wiederrecht; N F Campbell; M M Martin; S Bourgeois
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

4.  The immunophilin FKBP52 specifically binds to tubulin and prevents microtubule formation.

Authors:  Béatrice Chambraud; Hamida Belabes; Virginie Fontaine-Lenoir; Arlette Fellous; Etienne Emile Baulieu
Journal:  FASEB J       Date:  2007-04-13       Impact factor: 5.191

5.  Conformational change as one of the earliest alterations of tau in Alzheimer's disease.

Authors:  C L Weaver; M Espinoza; Y Kress; P Davies
Journal:  Neurobiol Aging       Date:  2000 Sep-Oct       Impact factor: 4.673

6.  Subcellular rearrangement of hsp90-binding immunophilins accompanies neuronal differentiation and neurite outgrowth.

Authors:  Héctor R Quintá; Darío Maschi; Celso Gomez-Sanchez; Graciela Piwien-Pilipuk; Mario D Galigniana
Journal:  J Neurochem       Date:  2010-09-28       Impact factor: 5.372

7.  Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1.

Authors:  J Zou; Y Guo; T Guettouche; D F Smith; R Voellmy
Journal:  Cell       Date:  1998-08-21       Impact factor: 41.582

8.  Expression and characterization of human FKBP52, an immunophilin that associates with the 90-kDa heat shock protein and is a component of steroid receptor complexes.

Authors:  D A Peattie; M W Harding; M A Fleming; M T DeCenzo; J A Lippke; D J Livingston; M Benasutti
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

9.  CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.

Authors:  Hideki Shimura; Daniel Schwartz; Steven P Gygi; Kenneth S Kosik
Journal:  J Biol Chem       Date:  2003-11-10       Impact factor: 5.157

10.  A Comparison of the Dynamics of S100B, S100A1, and S100A6 mRNA Expression in Hippocampal CA1 Area of Rats during Long-Term Potentiation and after Low-Frequency Stimulation.

Authors:  Pavel D Lisachev; Mark B Shtark; Olga O Sokolova; Vladimir O Pustylnyak; Mary Yu Salakhutdinova; Oleg I Epstein
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-08-30
View more
  11 in total

Review 1.  HSP90AB1: Helping the good and the bad.

Authors:  Michael Haase; Guido Fitze
Journal:  Gene       Date:  2015-09-07       Impact factor: 3.688

2.  Q-bodies monitor the quinary state of the protein fold.

Authors:  Daniela Martino Roth; William E Balch
Journal:  Nat Cell Biol       Date:  2013-10       Impact factor: 28.824

Review 3.  Therapeutic Strategies for Restoring Tau Homeostasis.

Authors:  Zapporah T Young; Sue Ann Mok; Jason E Gestwicki
Journal:  Cold Spring Harb Perspect Med       Date:  2018-01-02       Impact factor: 6.915

Review 4.  The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer's Disease.

Authors:  Yanuar Alan Sulistio; Klaus Heese
Journal:  Mol Neurobiol       Date:  2015-01-07       Impact factor: 5.590

Review 5.  Targeting Hsp90 and its co-chaperones to treat Alzheimer's disease.

Authors:  Laura J Blair; Jonathan J Sabbagh; Chad A Dickey
Journal:  Expert Opin Ther Targets       Date:  2014-07-29       Impact factor: 6.902

Review 6.  The emerging role of peptidyl-prolyl isomerase chaperones in tau oligomerization, amyloid processing, and Alzheimer's disease.

Authors:  Laura J Blair; Jeremy D Baker; Jonathan J Sabbagh; Chad A Dickey
Journal:  J Neurochem       Date:  2015-02-24       Impact factor: 5.372

7.  Comparative analysis of autophagy and tauopathy related markers in cerebral ischemia and Alzheimer's disease animal models.

Authors:  Javier G Villamil-Ortiz; Gloria P Cardona-Gomez
Journal:  Front Aging Neurosci       Date:  2015-05-19       Impact factor: 5.750

Review 8.  Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.

Authors:  Lindsey B Shelton; John Koren; Laura J Blair
Journal:  Front Neurosci       Date:  2017-12-22       Impact factor: 4.677

Review 9.  Mechanistic Insights into the Role of Molecular Chaperones in Protein Misfolding Diseases: From Molecular Recognition to Amyloid Disassembly.

Authors:  Rubén Hervás; Javier Oroz
Journal:  Int J Mol Sci       Date:  2020-12-02       Impact factor: 5.923

10.  Structure and pro-toxic mechanism of the human Hsp90/PPIase/Tau complex.

Authors:  Javier Oroz; Bliss J Chang; Piotr Wysoczanski; Chung-Tien Lee; Ángel Pérez-Lara; Pijush Chakraborty; Romina V Hofele; Jeremy D Baker; Laura J Blair; Jacek Biernat; Henning Urlaub; Eckhard Mandelkow; Chad A Dickey; Markus Zweckstetter
Journal:  Nat Commun       Date:  2018-10-31       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.